Comment Deadline: FDA Oncology Center of Excellence

The Food and Drug Administration (FDA) is soliciting public comments on a docket titled "Oncology Center of Excellence (OCE)" to collect recommendations regarding the FDA's OCE. Specifically, the Agency solicits comments regarding what stakeholders desire of the OCE in terms of structure, function, regulatory purview, and activity.

Members of the public may submit comments by mail or at Regulations.gov. More information is available via the Federal Register notice.

Event Date
Monday, April 16, 2018 - 5:00pm